08 June 2018
This week, IAM published their latest edition of the renowned IAM Patent 1000 Guide. De Clercq & Partners is very proud to announce that we have been endorsed as the only "Highly recommended" of Belgium's patent prosecution firms.
Intellectual Asset Management (IAM) identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions. The list is based on interviews with hundreds of lawyers and attorneys in the field, as well as their clients.
IAM commends De Clercq & Partners for its "exceptional responsiveness and diligence", emphasizing that "with an eye for detail, the team is indispensable to clients and foreign associates seeking advice in European and global strategic patent matters". Moreover, this year's IAM Patent 1000 Guide applauds that our "team now asserts dominance in a variety of industries", while it is "founded with one foot firmly in the world of biotechnology and life sciences". Finally, it is stated that our "firm’s pre-eminent standing in the market is testament to its technical expertise, abilities in contentious work and masterly handling of appellate work before the EPO".
Additionally, IAM has singled out four of our Patent Attorneys to be featured. Firstly, our Founding Partner and European & Belgian Patent Attorney Ann De Clercq ("the beating heart of the practice") is commended for her "command of matters", which "earned her the respect of her peers and chairmanship of the Biotechnology Committee of the Institute of Professional Representatives before the EPO". Secondly, Partner and European/Belgian Patent Attorney Koen Vanhalst is sure to deliver with extreme efficiency. Sakina Bounaga, Partner, European Patent Attorney and a "chemical and biotech maven", is deemed "crucial to the firm’s successes in huge volumes of chemical work". Liesbet Paemen, Partner and European Patent Attorney, is praised for both her "extreme diligence and availability around the clock" and for "shares her ample wisdom at a range of academic institutions".
Read the recommendation in full via the link.